NIH-funded research R21 grant

Investigating cholesterol metabolism in multiple system atrophy

Official title: Abnormalities of cholesterol metabolism in multiple system atrophy

Funded at Columbia University Health Sciences · NIH-10792884 · Data updated 2026-11-12

This study is looking at how cholesterol levels change in people with multiple system atrophy (MSA) to see if it can help us find new ways to treat this condition, and we’d love for patients to help by sharing some samples.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startMarch 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$205,625
NIH project number5R21AG077243-02
Project IDNIH-10792884 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with multiple system atrophy who are experiencing symptoms related to the condition.

Less likely to help

Patients with other neurodegenerative diseases or those without a diagnosis of multiple system atrophy may not benefit from this research.

What this research studies

This research focuses on understanding how cholesterol metabolism is affected in patients with multiple system atrophy (MSA), a neurodegenerative condition that leads to coordination and movement difficulties. The study aims to explore the relationship between cholesterol levels and Coenzyme Q, a vital molecule for cell function, particularly in the brain. By examining these metabolic pathways, researchers hope to uncover potential therapeutic targets that could lead to new treatments for MSA. Patients may be involved in providing biological samples to help elucidate these mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to the development of new therapies that modify the progression of multiple system atrophy.

How similar studies have gone: While the specific focus on cholesterol metabolism in MSA is novel, similar research in other neurodegenerative diseases has shown promising results in understanding metabolic pathways.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Quinzii, Catarina M. — Columbia University Health Sciences
  • Study coordinator: Quinzii, Catarina M.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.